If you can’t explain a clinical trial simply, you don’t understand it deeply enough.
Writing and reviewing articles for MedBound Times forced me to dismantle my academic writing habits. In research papers, we rely heavily on dense nomenclature—terms like “pleiotropic cytokine cascades” or “epigenetic methylation loci”—which serve as precise shortcuts among specialists. But communicating medical breakthroughs to a broader community requires stripping away jargon without sacrificing scientific accuracy. It demands finding the core narrative arc: why does this mechanism matter to a patient, what clinical problem does it solve, and what are its real-world limitations?
Scientific literacy among the public depends on researchers who can bridge the gap between benchside data and human stories.
What is your go-to strategy for explaining a complex biological concept to someone outside your field?
MBH/PS